Phage Display System for Disulfide-Stabilized scFv Expression

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The instability of single chain variable fragments (scFv) leads to aggregation and biases in antibody gene product reproduction on phage surfaces, limiting their application in biotechnology and medicine, and disulfide-stabilized scFv formats have not been successfully expressed on phage surfaces due to decreased yield.

Innovation Solution

Optimized signal sequences are identified and used to facilitate the production of disulfide-stabilized single chain antibodies, enabling their expression and display on phage surfaces through the creation of a phage display system that stabilizes the sc-dsFv format, improving yield and fidelity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If disulfide-stabilized single chain antibody (sc-dsFv) format is used to stabilize the structure, then stability and fidelity of antibody gene product reproduction are improved, but expression yield on phage surface decreases severely

Engineering Contradiction:
Improvestability of scFv structureVSAvoidexpression yield on phage surface
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention changes the amino acid sequence parameters of the signal peptide by introducing 10 randomized positions (X1-X10) that can be any of the 20 naturally occurring amino acids. This creates a library of signal peptide variants that are screened to identify sequences that optimize both the stability of sc-dsFv structure and the expression yield on phage surface, resolving the contradiction between these two parameters.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention performs preliminary optimization of the signal peptide sequence before the actual expression of sc-dsFv on phage surface. By pre-screening signal peptide variants in a library format, the optimal signal sequence is identified in advance, which then enables high-yield expression of stable sc-dsFv structures without the need for subsequent optimization steps.

Inventive Principle:
Principle #10Preliminary action

2Device complexity

If conventional signal sequences are used for phage-displayed sc-dsFv expression, then the expression system is simple, but expression is not viable due to severely decreased yield

Engineering Contradiction:
Improvesimplicity of expression systemVSAvoidexpression yield of sc-dsFv
Core Design Contradiction:
Device complexityVSProductivity

Solution Approach 1:

The invention modifies the signal peptide sequence parameters by introducing 10 randomized positions (X1-X10) into the conventional signal sequence framework. This creates a diversified library of signal peptide variants that maintain the basic structure and function of conventional signals while enabling high-yield expression of sc-dsFv on phage surface, thus preserving system simplicity while dramatically improving productivity.

Inventive Principle:
Principle #35Parameter changes

3Length of moving object

If single chain variable fragment (scFv) is used as scaffold, then tissue-penetrating capability is improved, but structural stability decreases leading to aggregation

Engineering Contradiction:
Improvesize of antibody fragmentVSAvoidstructural stability of scFv
Core Design Contradiction:
Length of moving objectVSReliability

Solution Approach 1:

The invention creates a composite structure by combining the small scFv scaffold with a disulfide bond network. The disulfide bonds formed between cysteine residues at specific positions create a stabilized composite structure that maintains the small size and tissue-penetrating capability of scFv while adding the structural stability needed to prevent aggregation and improve reliability.

Inventive Principle:
Principle #40Composite materials

Data Source

PatentUS9951121B2Phage displaying system expressing single chain antibody
Publication Date: 2018.04.24 ACAD SINICA
  • US9951121B2 patent drawing
  • US9951121B2 patent drawing
  • US9951121B2 patent drawing

AI summary

Disclosed are nucleic acid libraries for identifying a signal peptide that facilitates production of disulfide-stabilized single chain antibody, and for facilitating production of a disulfide-stabilized single chain antibody. Also disclosed are host cell libraries and phage libraries including the nucleic acid libraries. Further disclosed are methods for identifying a signal peptide that facilitates production of disulfide-stabilized single chain antibody, and methods for producing a disulfide-stabilized single chain antibody and non-fusion form thereof.